Holen Sie sich die Stockscreener-App
3.1197
1.46%
0.0397
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ACHV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.08
Offen:
$3.12
24-Stunden-Volumen:
456.79K
Relative Volume:
0.42
Marktkapitalisierung:
$159.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.94M
KGV:
-2.8105
EPS:
-1.11
Netto-Cashflow:
$-24.95M
1W Leistung:
-1.11%
1M Leistung:
+1.46%
6M Leistung:
+43.35%
1J Leistung:
-37.50%
1-Tages-Spanne:
$3.09
$3.17
1-Wochen-Bereich:
$3.08
$3.475
52-Wochen-Spanne:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Firmenname
Achieve Life Sciences Inc
Sektor
Branche
Telefon
425-686-1500
Adresse
22722 29TH DR. SE, SEATTLE, BC
Vergleichen Sie ACHV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
3.125 | 157.40M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Strong Buy |
| 2023-05-10 | Bestätigt | Maxim Group | Buy |
| 2021-06-23 | Eingeleitet | Oppenheimer | Outperform |
Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten
Price momentum metrics for Achieve Life Sciences Inc. explained2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
What machine learning models say about Achieve Life Sciences Inc.Portfolio Update Summary & Verified High Yield Trade Plans - newser.com
Using R and stats models for Achieve Life Sciences Inc. forecastingJuly 2025 Setups & Expert Verified Stock Movement Alerts - newser.com
Using data models to predict Achieve Life Sciences Inc. stock movementJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Ranking Achieve Life Sciences Inc. among high performing stocks via toolsWeekly Volume Report & Technical Pattern Recognition Alerts - newser.com
What momentum shifts mean for Achieve Life Sciences Inc.July 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Relative strength of Achieve Life Sciences Inc. in sector analysisWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Is Achieve Life Sciences Inc. meeting your algorithmic filter criteria2025 Top Decliners & Daily Entry Point Alerts - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
How Achieve Life Sciences Inc. (SP4P) stock stacks up against competitorsJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
Is Achieve Life Sciences Inc a good long term investmentEarnings Call Summaries & Predict Volatility With Our Neural Network - earlytimes.in
What to expect from Achieve Life Sciences Inc. in the next 30 daysJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
What earnings revisions data tells us about Achieve Life Sciences Inc.July 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year - simplywall.st
How forex fluctuations impact Achieve Life Sciences Inc. (SP4P) stockJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Achieve Life Sciences' (ACHV) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Achieve Life Sciences Announces Leadership Change - TipRanks
Achieve Life Sciences announces resignation of chief medical officer and president - Investing.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Using AI based signals to follow Achieve Life Sciences Inc.2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock stage a strong rebound this quarterDollar Strength & Community Supported Trade Ideas - newser.com
Understanding Achieve Life Sciences Inc.’s price movementEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
How Achieve Life Sciences Inc. (SP4P) stock compares with top peersMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
How to use Fibonacci retracement on Achieve Life Sciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - newser.com
Custom strategy builders for tracking Achieve Life Sciences Inc.Market Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Published on: 2025-10-02 18:42:53 - newser.com
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewswire
161,000-Share Option Grant: Achieve Life Sciences Awards to 5 New Hires — 10‑Year Term, 25% Vests After 1 Year - Stock Titan
Published on: 2025-10-01 06:37:19 - newser.com
Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now (NASDAQ:ACHV) - Seeking Alpha
Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Achieve Life Sciences Inc-Aktie (ACHV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):